Novartis Ag (NVS) Short-term Investments (2009 - 2026)

Novartis Ag (NVS) has 16 years of Short-term Investments data on file, last reported at $100.0 million in Q1 2026.

• Quarterly Short-term Investments rose 370.27% year-over-year to $100.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.0 million (up 370.27% YoY) and the FY2025 annual result came in at $155.0 million, up 400.0% from the prior year.
• Short-term Investments fell to $100.0 million in Q1 2026 per NVS's latest filing, from $155.0 million in the prior quarter.
• The five-year high for Short-term Investments was $11.4 billion in Q4 2022, with the low at -$13.2 billion in Q2 2022.
• Average Short-term Investments over 5 years is -$156.7 million, with a median of $18.0 million recorded in 2022.
• Year-over-year, Short-term Investments plunged 29306.67% in 2022 and jumped 5700.0% in 2023.
• Novartis Ag's Short-term Investments stood at $11.4 billion in 2022, then tumbled by 105.62% to -$641.0 million in 2023, then soared by 104.84% to $31.0 million in 2024, then jumped by 400.0% to $155.0 million in 2025, then tumbled by 35.48% to $100.0 million in 2026.
• Business Quant data shows NVS's Short-term Investments at $100.0 million in Q1 2026, $155.0 million in Q4 2025, and $197.0 million in Q3 2025.